Xeris Pharmaceuticals Inc

Healthcare · Drug Manufacturers - Specialty & Generic

9.10$ +1.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Xeris Pharmaceuticals Inc (XERS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 412 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XERS
Line item	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	34	–	–	–	45	62	138	138	120	161	134	128	109	116	166	170	159	168	151	131	304	338	319	303	345	321	329	328	323	337	332	321	323	315	335	370	384	392	412
Current Assets	33	32	–	–	44	60	137	136	118	153	126	106	87	106	156	163	152	161	145	124	143	178	161	149	187	166	156	158	156	173	170	163	168	163	186	224	240	252	275
Cash	32	-32	–	–	42	58	135	76	46	62	67	56	20	39	102	38	38	67	64	59	67	104	95	84	122	51	46	46	67	63	58	59	72	58	59	92	111	112	122
Cash & Short-Term Investments	–	32	–	–	42	58	135	131	113	148	125	102	76	97	144	142	134	136	116	93	102	132	112	93	122	95	81	66	72	87	78	69	72	58	59	92	111	112	122
Receivables	0.1	–	–	–	1.2	0.3	1.1	1.7	2.9	3.6	0.8	0.9	4.7	3.3	3.9	12	6.9	8.9	12	14	17	23	26	28	31	31	30	46	39	37	42	41	40	46	53	54	51	56	58
Inventory	–	–	–	–	0.0	–	0.0	0.0	–	0.0	–	–	2.2	2.2	4.8	5.6	8.4	12	12	14	18	17	18	20	25	29	37	38	39	41	43	45	48	53	67	67	69	74	81
Property, Plant & Equipment	0.3	–	–	–	0.8	1.1	1.1	1.8	2.0	7.4	7.7	8.0	7.9	7.6	7.4	6.9	6.7	6.8	6.7	6.7	6.6	6.3	6.2	5.8	9.5	–	30	30	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	23	23	23	23	23	23	23	23	23	23	23	23	23	23	23	23	23	23	23
Intangible Assets	–	–	–	–	–	–	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	131	129	126	123	121	118	115	112	110	107	104	102	99	96	94	91	88	85	83
Total Liabilities	2.6	–	–	–	103	29	29	42	45	54	59	84	95	89	141	156	125	123	132	134	209	241	245	248	299	291	315	324	329	346	351	349	353	351	354	371	370	379	422
Current Liabilities	2.5	–	–	–	4.9	9.2	9.2	8.2	10	13	21	18	27	22	23	27	28	27	35	37	79	66	65	69	74	81	80	87	95	73	75	91	100	95	95	116	110	119	190
Short-Term Debt	–	–	–	–	2.6	7.6	7.5	6.3	8.2	11	3.0	16	–	–	–	–	–	–	–	–	–	0.3	–	1.4	1.6	1.4	1.9	2.4	3.5	4.6	5.3	21	21	18	6.2	6.2	6.2	6.3	70
Accounts Payable	1.3	–	–	–	2.0	0.8	0.6	0.6	0.9	1.4	1.8	1.7	5.6	3.8	4.4	4.7	3.1	4.8	5.2	4.3	8.9	11	6.6	3.9	4.6	12	12	12	12	7.1	5.8	7.5	2.3	6.4	9.5	6.5	3.1	11	9.3
Long-Term Debt	–	–	–	–	–	18	18	32	32	32	29	58	58	58	109	119	87	87	87	88	88	138	138	139	187	188	188	190	191	230	230	216	217	218	219	219	220	221	189
Shareholders' Equity	31	31	–	–	-58	33	109	95	75	107	75	44	14	27	24	14	34	44	20	-2.5	95	96	74	55	45	30	14	3.9	-6.8	-9.2	-19	-28	-30	-35	-19	-0.9	14	13	-9.7
Retained Earnings	-34	–	–	–	-61	-72	-85	-100	-121	-146	-180	-213	-246	-275	-300	-316	-337	-356	-383	-409	-460	-494	-520	-542	-555	-572	-591	-604	-617	-636	-651	-667	-672	-681	-683	-682	-671	-669	-700
Shares Outstanding	5.8	2.0	2.0	2.0	2.1	2.2	4.2	21	21	24	27	27	27	33	38	46	54	61	66	66	122	135	136	136	136	137	137	138	138	141	148	149	149	152	156	178	180	178	173

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings